Bone News and Research

RSS

Cocoa and blood pressure: an interview with Dr Karin Ried

The compounds in cocoa responsible for blood pressure reduction are called flavanols or polyphenols. Flavanols are also found in green tea, dark berries or red wine.

24 Aug 2012

Scientists develop reliable method to convert adult blood cells into iPSCs

Johns Hopkins scientists have developed a reliable method to turn the clock back on blood cells, restoring them to a primitive stem cell state from which they can then develop into any other type of cell in the body.

24 Aug 2012

Early exposure to antibiotics primes children for obesity later in life

Researchers at NYU School of Medicine have made a novel discovery that could have widespread clinical implications, potentially affecting everything from nutrient metabolism to obesity in children.

23 Aug 2012

Life-quality concerns for multiple myeloma survivors

Care of patients with multiple myeloma should not end with the achievement of long-term survival, suggests research indicating many experience poor health-related quality of life in the decade after diagnosis.

22 Aug 2012

Blood cells returned to stem cell state by Johns Hopkins researchers

22 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

Radiation therapy alone no longer the best choice for early follicular lymphoma

A University of Rochester Medical Center study published in the Journal of Clinical Oncology, challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis.

22 Aug 2012

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Arteriocyte, a leading clinical stage biotechnology company developing cellular based therapies to treat human diseases, announced today the successful award of another grant by the National Institute of Health for the use of the NANEX platform in Hematopoietic Reconstitution Using Ex Vivo Expanded Umbilical Cord Blood CD34+ Stem Cells.

22 Aug 2012

FDA acceptance achieved by Greatbatch Medical thanks to help from Ceram

Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.

21 Aug 2012

Stem-cell therapy holds promise for postinjury arthritis prevention

A novel stem-cell treatment may hold the key to treating osteoarthritis triggered by joint injury, suggest results from an animal study.

21 Aug 2012

Tips for menopause symptom relief

An estimated 6,000 women in the U.S. reach menopause every day (about two million annually).The most common menopausal complaints include hot flashes, sleep disturbances, anxiety, poor mood, and physical and mental exhaustion. Hot flashes affect 80 percent of peri- or postmenopausal women, with 30 percent reporting hot flashes severe enough to seriously affect their quality of life.

21 Aug 2012

FSH-specific polyclonal antibody might offer more effective way to prevent osteoporosis

A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.

21 Aug 2012

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

Medivir AB, the research-based pharmaceutical company focused on the development of high-value treatments for infectious diseases, is reporting today that a clinical phase Ib trial of the company's candidate drug (CD) MIV-711 has commenced.

21 Aug 2012

Bonovo’s first PEEK lateral interbody fusion cage now available in China

Bonovo Orthopedics, Inc. announced today that it has launched the first PEEK lateral interbody fusion cage, Cross-Fuse in China.

21 Aug 2012

Mayo Clinic receives approval for construction of new building on Phoenix campus

Mayo Clinic has been granted approval for construction of a 217,200 square-foot building on its Phoenix campus, a major expansion that will create a single-site, integrated Cancer Center. Mayo Clinic Cancer Center is the only National Cancer Institute-designated comprehensive cancer center with a multi-site, national presence, which allows us to serve a broad and diverse group of patients.

21 Aug 2012

Injectable controlled-release capsules against gum disease

Scientists are trying to open a new front in the battle against gum disease, the leading cause of tooth loss in adults and sometimes termed the most serious oral health problem of the 21st century. They described another treatment approach for the condition in a report here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

20 Aug 2012

ARIAD initiates multi-center ponatinib Phase 1/2 clinical trial for CML in Japan

ARIAD Pharmaceuticals, Inc. today announced the initiation of a multi-center Phase 1/2 clinical trial in Japan of ponatinib, the Company's investigational BCR-ABL inhibitor.

20 Aug 2012

NYU Langone's Hospital for Joint Diseases achieves Magnet recognition by ANCC

NYU Langone Medical Center's Hospital for Joint Diseases (HJD) has achieved Magnet recognition by the American Nurses Credentialing Center (ANCC), the international accrediting body that recognizes healthcare organizations focused on nursing excellence.

18 Aug 2012

Ion levels poor indicator for hip arthroplasty debris

Research shows that plasma metal ion analysis is only moderately effective at identifying patients with adverse reaction to metal debris following metal-on-metal hip arthroplasty.

17 Aug 2012

Intake of Mediterranean diet enriched with olive oil may increase serum osteocalcin concentrations

A study to be published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) shows consumption of a Mediterranean diet enriched with olive oil for two years is associated with increased serum osteocalcin concentrations, suggesting a protective effect on bone.

16 Aug 2012